IRIS
CIRIONI, Oscar
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.635
EU - Europa 7.247
AS - Asia 6.876
SA - Sud America 1.484
AF - Africa 393
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 11
Totale 30.664
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.376
SG - Singapore 2.327
VN - Vietnam 1.380
RU - Federazione Russa 1.257
UA - Ucraina 1.211
BR - Brasile 1.131
CN - Cina 1.070
IT - Italia 943
DE - Germania 685
IE - Irlanda 680
SE - Svezia 664
TR - Turchia 586
HK - Hong Kong 560
FR - Francia 471
DK - Danimarca 433
FI - Finlandia 353
GB - Regno Unito 253
KR - Corea 245
CI - Costa d'Avorio 195
IN - India 150
AR - Argentina 125
CA - Canada 110
BD - Bangladesh 108
MX - Messico 102
NL - Olanda 67
EC - Ecuador 62
JP - Giappone 61
ZA - Sudafrica 58
IQ - Iraq 54
ID - Indonesia 50
CO - Colombia 48
PL - Polonia 46
MA - Marocco 42
PK - Pakistan 41
UZ - Uzbekistan 35
VE - Venezuela 35
AT - Austria 33
PH - Filippine 30
ES - Italia 29
PY - Paraguay 28
BE - Belgio 27
IR - Iran 27
PE - Perù 20
MY - Malesia 19
CL - Cile 18
EG - Egitto 18
TN - Tunisia 18
RO - Romania 15
LT - Lituania 14
KE - Kenya 13
KZ - Kazakistan 13
NP - Nepal 13
SA - Arabia Saudita 13
JO - Giordania 12
AE - Emirati Arabi Uniti 11
AU - Australia 10
OM - Oman 10
UY - Uruguay 10
BG - Bulgaria 9
DO - Repubblica Dominicana 9
DZ - Algeria 9
ET - Etiopia 9
PS - Palestinian Territory 9
TH - Thailandia 9
EU - Europa 8
IL - Israele 8
AZ - Azerbaigian 7
HR - Croazia 7
PA - Panama 7
CH - Svizzera 6
RS - Serbia 6
AL - Albania 5
BO - Bolivia 5
CR - Costa Rica 5
CY - Cipro 5
SN - Senegal 5
TT - Trinidad e Tobago 5
CG - Congo 4
GR - Grecia 4
JM - Giamaica 4
LY - Libia 4
MD - Moldavia 4
NG - Nigeria 4
PT - Portogallo 4
TW - Taiwan 4
AO - Angola 3
BH - Bahrain 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
HN - Honduras 3
HU - Ungheria 3
KW - Kuwait 3
LB - Libano 3
MT - Malta 3
NI - Nicaragua 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
A1 - Anonimo 2
BB - Barbados 2
Totale 30.623
Salva come PNG Salva come JPEG
Città #
Ashburn 2.343
Singapore 1.400
Jacksonville 1.207
Chandler 1.054
Dallas 883
Fairfield 832
Dublin 671
San Jose 647
Boardman 616
Hong Kong 536
Wilmington 490
Ho Chi Minh City 448
Woodbridge 401
New York 378
Hanoi 353
Seattle 322
Houston 318
Council Bluffs 316
Ann Arbor 279
Beijing 277
Des Moines 265
Moscow 262
Lawrence 254
Princeton 254
Cambridge 251
San Mateo 247
Lauterbourg 221
Los Angeles 220
The Dalles 217
Abidjan 195
Hefei 168
Munich 125
San Diego 119
Turin 114
São Paulo 98
Milan 97
Buffalo 94
Centro 91
Da Nang 75
Orem 66
Helsinki 64
Turku 64
Santa Clara 62
Redmond 58
London 56
Chicago 48
Tokyo 46
Haiphong 43
Guangzhou 42
Montreal 41
Chennai 38
Shanghai 38
Warsaw 38
Ancona 35
Miano 35
Tashkent 34
Rio de Janeiro 33
Washington 33
Columbus 31
Mexico City 31
Nuremberg 31
Rome 30
Denver 29
Izmir 29
Johannesburg 29
Norwalk 28
Brussels 26
Brooklyn 25
Manchester 25
Brasília 24
Atlanta 23
Mumbai 23
Wuhan 23
Falls Church 22
Hải Dương 22
Marche 22
Amsterdam 21
Phoenix 21
Belo Horizonte 20
Poplar 20
Porto 20
San Francisco 20
Biên Hòa 19
Guayaquil 19
Dhaka 17
Ottawa 17
Stockholm 17
Vienna 17
Baghdad 16
Boston 16
Bắc Ninh 16
Can Tho 16
Curitiba 16
Frankfurt am Main 16
Salt Lake City 16
Buenos Aires 15
Caracas 15
Kilburn 15
New Delhi 15
Pune 15
Totale 18.900
Salva come PNG Salva come JPEG
Nome #
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 333
Antimicrobial Resistance: A Challenge for the Future 304
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 266
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 229
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture. 208
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 208
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 201
Anticryptosporidial activity of paromomycin. 199
Enhanced efficacy of combinations of pexiganan with colistin versus Acinetobacter baumannii in experimental sepsis 199
Characterization of a new transferable MDR plasmid carrying the pbp5 gene from a clade B commensal Enterococcus faecium 190
Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture. 189
Characterization of a Multiresistance Plasmid Carrying the optrA and cfr Resistance Genes From an Enterococcus faecium Clinical Isolate 187
Characterization and clonal diffusion of ceftaroline non-susceptible mrsa in two hospitals in central Italy 185
Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. 184
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 183
Antimicrobial activity of polycationic peptides 182
Efficacy of the quorum sensing inhibitor FS10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound 181
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 175
Ceftazidime-Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study 174
Late or missed HIV diagnosis during pregnancy is still occurring in a high-income country and represents a high risk of MTCT 172
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. 171
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 165
Trend of clinical vancomycin-resistant enterococci isolated in a regional Italian hospital from 2001 to 2018 165
Protective effects of the combination alpha-helical antimicrobial peptides and rifampin in three rat models of Pseudomonas aeruginosa infection 159
Use of dalbavancin in skin, bone and joint infections: A real-life experience in an Italian center 159
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 158
Antimicrobial activity of aztreonam in combination with old and new β-lactamase inhibitors against mbl and esbl co-producing gram-negative clinical isolates: Possible options for the treatment of complicated infections 157
Epidemiology and microbiology of surgical wound infections. 155
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 154
Effects of the Infusion of 4% or 20% Human Serum Albumin on the Skeletal Muscle Microcirculation in Endotoxemic Rats 153
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 151
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 150
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 149
Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines. 149
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 148
In vitro activity of Protegrin-1, alone and in combination with clinically useful antibiotics, against Acinetobacter baumannii strains isolated from surgical wounds 148
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 147
[Giardiasis: a parasitic disease of continued topicality. Study of prevalence among a selected adult population] 147
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 147
Spread of colistin resistance gene mcr-1 in Italy: characterization of the mcr-1.2 allelic variant in a colistin-resistant blood isolate of Escherichia coli 146
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Grampositive cocci isolated from surgical wound infections 146
In-vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity. 145
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 144
Tachyplesin III and Granulocyte-Colony Stimulating Factor Enhance the Efficacy of Piperacillin/Tazobactam in a Neutropenic Mouse Model of Polymicrobial Peritonitis 143
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 142
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. 141
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 141
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. 139
Effect of omiganan on colonic anastomosis healing in a rat model of peritonitis 139
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 138
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 138
Efficacy of pexiganan combination with tigecycline in a mouse model of Pseudomonas aeruginosa sepsis 138
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 137
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp. 136
High rate of ceftobiprole resistance among clinical methicillin-resistant Staphylococcus aureus isolates from a hospital in central Italy 136
Clinical and microbiological features of ceftolozane/tazobactam-resistant Pseudomonas aeruginosa isolates in a university hospital in central Italy 135
Antimicrobial peptides (Temporin A and Iseganan IB-367): effect on the cysticerci of Taenia crassiceps. 134
Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis 133
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 133
In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. 133
whISOBAX™ inhibits bacterial pathogenesis and enhances the effect of antibiotics 133
Review: A safety profile of dalbavancin for onand off-label utilization 133
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 132
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 132
Animal models commonly used to study quorum-sensing inhibitors. 132
Role of daptomycin on burn wound healing in an animal methicillin-resistant staphylococcus aureus infection model 132
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 131
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 131
Anticryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systems. 131
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. 130
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 130
ER-mitochondria association negatively affects wound healing by regulating NLRP3 activation 129
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 129
Supplementation with tocotrienols from Bixa orellana improves the in vivo efficacy of daptomycin against methicillin-resistant Staphylococcus aureus in a mouse model of infected wound 129
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 129
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 128
Safety and efficacy of vaccines during covid-19 pandemic in patients treated with biological drugs in a dermatological setting 127
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 126
Antimicrobial Activity of Different Antimicrobial Peptides (AMPs) Against Clinical Methicillin-resistant Staphylococcus aureus (MRSA) 126
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 125
Antiretroviral therapy management and rationalisation of available resources 125
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 124
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 124
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 123
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]. 123
Rate and determinants of residual viremia in multidrug-experienced patients successfully treated with raltegravir-based regimens 123
Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii. 122
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 122
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 122
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 121
Urinary catheters and biofilm formation 121
Efficacy of cathelicidin ll-37 in an mrsa wound infection mouse model 121
Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management 120
The Antimicrobial Peptide Tachyplesin III Coated alone and in Combination with Intraperitoneal Piperacillin-Tazobactam Prevents Ureteral Stent Biofilm Formation in a Rat Subcutaneous Pouch Model of Pseudomonas Infection. 120
The antimicrobial peptide Tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model 120
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. 120
In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients. 120
A In vitro and in vivo activity of aurintricarboxylic acid against Cryptosporidium parvum 120
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 119
In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes 119
Totale 15.022
Salva come PNG Salva come JPEG
Categoria #
all - tutte 137.558
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.558
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.026 132 443 13 105 33 147 91 117 142 265 131 407
2022/20233.451 341 334 254 246 267 516 7 182 884 18 273 129
2023/20241.976 363 46 133 319 347 415 34 55 22 23 26 193
2024/20254.249 544 333 248 131 156 213 419 169 892 227 417 500
2025/202611.679 676 930 963 1.299 1.091 751 2.100 1.151 1.069 912 263 474
2026/2027283 283 0 0 0 0 0 0 0 0 0 0 0
Totale 31.012